The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.
Saved in:
| Title: | The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab. |
|---|---|
| Authors: | Provan, Sella Aarrestad1 sellaprovan@gmail.com, Berg, Inger Jorid1, Hammer, Hilde Berner1, Mathiessen, Alexander1, Kvien, Tore Kristian1, Semb, Anne Grete2 |
| Source: | PLoS ONE. Jun2015, Vol. 10 Issue 6, p1-8. 8p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
